Zura Bio Announces Oversubscribed $112.5 Million Private PlacementBusiness Wire • 20 days agoZura Bio Limited (Nasdaq: ZURA) (Zura Bio), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced that it...